Crohn’s Disease

June 16, 2015June 16, 2015

CCFA Celebrates Fatherhood at Take Steps Fundraising Walks

Crohn's Disease, News

In preparation for the Crohn’s and Colitis Foundation of America‘s (CCFA) Take Steps fundraising program, a nationwide event featuring a series of fundraising walks, the non-profit organization is also celebrating fatherhood. CCFA ... Read more

June 15, 2015September 16, 2016

Vitamin D Supplementation May Offer a Beneficial Effect for Crohn’s Disease Patients

Crohn's Disease, News

An international team led by researchers at St. James’s Hospital in Dublin, Ireland, recently reported that vitamin D may have a beneficial impact on the intestinal barrier dysfunction associated with ... Read more

June 10, 2015June 10, 2015

Non-Invasive Accupoint Stimulation May Offer New Bioelectronics Approach To Crohn’s Treatment

Crohn's Disease, News

An oral abstract presented on Tuesday June 9 at the International Neuromodulation Society 12th World Congress, which ran from June 6 to 11 at the Fairmont Queen Elizabeth Hotel in ... Read more

June 8, 2015June 8, 2015

First Infliximab Biosimilar Approved in Brazil For Crohn’s Disease

Crohn's Disease, News

The National Health Surveillance Agency (ANVISA) in Brazil has approved the commercialization of Remsima (infliximab), indicated for a series of conditions such as Crohn’s disease and ulcerative colitis, making it the first ... Read more

June 1, 2015June 1, 2015

Game-Changing IBD Population Health Management Platform Launched

Crohn's Disease, News

Elgin, Illinois based Sonar MD, LLC has announced the release of its Sonar MD Platform, an innovative cloud-based algorithm for secure engagement, monitoring and management of patients with chronic gastrointestinal ... Read more

May 28, 2015May 28, 2015

RedHill to Present Crohn’s Therapy at Upcoming Conference

Crohn's Disease, News

RedHill Biopharma recently announced in a press release that the company will be hosting a presentation at the upcoming Jefferies 2015 Global Healthcare Conference. Guy Goldberg, RedHill’s chief business officer, will discuss RedHill’s progress in developing late clinical-stage, ... Read more

May 27, 2015May 27, 2015

MEDI2070 Shows Clinical Benefit in Crohn’s Disease

Crohn's Disease, News

During Digestive Disease Week (May 16-19) in Washington, D.C., Bruce E. Sands, MD, of the Division of Gastroenterology at the Icahn School of Medicine in Mount Sinai, New York presented results where ... Read more

May 19, 2015May 19, 2015

UCB Presents Crohn’s Disease Therapy Evaluation Data For Cimzia at DDW

Crohn's Disease, News

Biopharmaceutical company UCB recently presented data on the study of the drug Cimzia for the treatment of Crohn’s disease at Digestive Disease Week 2015, which wraps up today in Washington, D.C. Cimzia was approved ... Read more

May 12, 2015September 28, 2016

Fecal Calprotectin Shown To Be Potential Biomarker for Crohn’s Disease Recurrence After Intestinal Resection

Crohn's Disease, News

New research revealed that fecal calprotectin levels may be a biomarker for assessing Crohn’s disease after intestinal resection. The study entitled ”Measurement of Fecal Calprotectin Improves Monitoring and Detection of ... Read more

May 8, 2015May 13, 2015

Crohn’s Research Awarded $400,000 SPARC Grant

Crohn's Disease, News

The Strategic Pharma-Academic Research Consortium (SPARC) for Translational Medicine has awarded its first grants, totaling more than $1.9 million, which will be invested to accelerate investigations into autoimmune conditions. Among the five winners ... Read more